Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat

Experimental Biology and Medicine

Volumn 235, Issue 10, 2010, Pages 1244-1256

  Al Dasooqi, Noor ^a,b   Gibson, Rachel J ^a,b   Bowen, Joanne M ^a,b   Logan, Richard M ^a,c   Stringer, Andrea M ^a,b   Keefe, Dorothy M ^a,b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c Division of Surgical Pathology   (Australia)

^d CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

Author keywords

Alimentary tract; Chemotherapy; Matrix metalloproteinases; Mucositis; Tissue inhibitors of metalloproteinases

Indexed keywords

EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN; INTERSTITIAL COLLAGENASE; IRINOTECAN; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ANTINEOPLASTIC AGENT; AUTACOID; CAMPTOTHECIN; MESSENGER RNA; PLASMINOGEN; PRIMER DNA;

ALIMENTARY TRACT MUCOSITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON; CONTROLLED STUDY; CORRELATION ANALYSIS; DARK AGOUTI RAT; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; JEJUNUM; MUCOSA INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INJURY; TISSUE LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GASTROENTERITIS; GENETICS; INTESTINE MUCOSA; METABOLISM; MUCOSITIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TOXICITY;

AGOUTI; RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CAMPTOTHECIN; COLON; DNA PRIMERS; FEMALE; GASTROENTERITIS; GENE EXPRESSION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; JEJUNUM; MATRIX METALLOPROTEINASES; MUCOSITIS; PLASMINOGEN; RATS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 77957832701     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010082     Document Type: Article

References (36)

1. Ma M, McLeod H. Lessons learned from the irinotecan metabolic pathway. Curr Med Chem 2003;10:41-9 (Pubitemid 36131648)
2. Gibson R, Bowen J, Alvarez E, Finnie J, Keefe D. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 2007;53:360-9 (Pubitemid 47415438)
3. Sharma R, Tobin P, Clarke S. Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol 2005;6:93-102 (Pubitemid 40197703)
4. Murphy B. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Supp Oncol 2007;5:13-21
5. Sonis S. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84
6. Stringer A, Gibson R, Bowen J, Ashton K, Logan R, Al-Dasooqi N, Yeoh A, Keefe D. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 2009;90:489-99
7. Logan R, Gibson R, Bowen J, Stringer A, Sonis S, Keefe D. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 2008;62:33-41 (Pubitemid 351537842)
8. Gibson R, Bowen J, Inglis M, Cummins A, Keefe D. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 2003;18:1095-100 (Pubitemid 37175953)
9. Bowen J, Gibson R, Cummins A, Tyskin A, Keefe D. Irinotecan changes gene expression in the small intestine of the rat with breast cancer. Cancer Chemother Pharmacol 2007;59:337-48 (Pubitemid 46025521)
10. Bowen J, Gibson R, Tsykin A, Stringer A, Logan R, Keefe D. Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. Int J Cancer 2007;121:1847-56 (Pubitemid 47417306)
11. Yeoh A, Bowen J, Gibson R, Keefe D. Nuclear factor κB (NFκB) and cyclooxygenase-2 (COX-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys 2005;63:1295-303 (Pubitemid 41628021)
12. Al-Dasooqi N, Gibson R, Bowen J, Keefe D. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis? Cancer Chemother Pharmacol 2009;64:1-9
13. Sonis S. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med 2002;13:380-9 (Pubitemid 36569342)
14. Clark I, Swingler T, Sampieri C, Edwards D. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008;40:1362-78
15. Manicone A, McGuire J. Matrix metalloproteinases as modulators of inflammation. Sem Cell Dev Biol 2008;19:34-41
16. Wolf M, Albrecht S, Marki C. Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 2008;40:1185-98
17. Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000;120:241-6
18. Stringer A, Gibson R, Logan R, Bowen J, Yeoh A, Keefe D. Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats. Cancer Biol Ther 2008;7:1919-25
19. Durigan J, Peviani S, Russo T, Delfino G, Ribeiro J, Cominetti M, Selistre-de-Araujo H, Salvini T. Effects of alternagin-C from Bothrops alternatus on gene expression and activity of metalloproteinases in regenerating skeletal muscle. Toxicon 2008;52:687-94
20. Vikman K, Ansar S, Edvinsson L. Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following subarachnoid hemorrhage in rats. J Neurosurg 2007;107:1015-55
21. Wasserman J, Zhu X, Schlichter L. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res 2007;1180:140-54 (Pubitemid 350018735)
22. Almarza A, Augustine S, Woo S. Changes in gene expression of matrix constituents with respect to passage of ligament and tendon fibroblasts. Ann Biomed Eng 2008;36:1927-33
23. Castro M, Rizzi E, GFigueiredo-Lopes L, Fernandes K, Bendhack L, Pitol D, Gerlach R, Tanus-Santos J. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 2008;198:320-31 (Pubitemid 351707391)
24. Fujisaki K, Tanabe N, Suzuki N, Mitsui N, Oka H, Ito K, Maeno M. The effect of IL-1α on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Life Sci 2006;78:1975-82 (Pubitemid 43319577)
25. Chen J, Rider D, Ruan R. Identification of valid housekeeping genes and antioxidant enzyme gene expression change in the aging rat liver. J Gerontol 2006;61A:20-7 (Pubitemid 43227798)
26. Bowen J, Gibson R, Keefe D, Cummins A. Cytotoxic chemotherapy up-regulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005;37:56-62 (Pubitemid 40314450)
27. Stringer A, Gibson R, Logan R, Bowen J, Yeoh A, Burns J, Keefe D. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med 2007;232:96-106 (Pubitemid 46091606)
28. Meijer M, Mieremet-Ooms M, Van Der Zon A, Van Duijn W, Van Hogezand R, Sier C, Hommes D, Lamers C, Verspaget H. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig Liver Dis 2007;39:733-9
29. Solberg A, Holmdahl L, Falk P, Palmgren I, Ivarsson M. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. Int J Colorectal Dis 2008;23:611-18
30. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001;293:293-7
31. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol 2005;37:283-8
32. Salmela M, Pender SL, Karjalainen-Lindsberg M, Puolakkainen P, MacDonald T, Saarialho-Kere U. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 2004;39:1095-104
33. Bowen J, Tsykin A, Stringer A, Logan R, Gibson R, Keefe D. Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tract. Toxicology 2010;269:1-12
34. Wu B, Crampton S, Hughes C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007;26:227-39 (Pubitemid 46329437)
35. Lin C, Tseng H, Hsieh H, Lee C, Wu C, Cheng C, Yang C. Tumor necrosis factor-alpha induced MMP9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Toxicol Appl Pharmacol 2008;229:386-98
36. Delclaux C, Delacourt C, D'Ortho M, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Resp Cell Mol Biol 1996;14:288-95